Chromadex CEO Rob Fried on NAD+, longevity, and the next frontier in cellular health

Longevity.Technology’s supplement brand, FLT recently launched its first consumer product, LONGEVITY. Central to this is a collaboration with ChromaDex, a leader in NAD+ research and supplementation.  The partnership combines advanced longevity science with a commitment to evidence-based health solutions. Rob Fried, CEO of ChromaDex, joined Longevity.Technology’s Phil Newman to discuss the latest breakthroughs in NAD+ […] The post Chromadex CEO Rob Fried on NAD+, longevity, and the next frontier in cellular health appeared first on Longevity.Technology.